$1.42
+0.04 (+2.54%)
Open$1.37
Previous Close$1.38
Day High$1.42
Day Low$1.36
52W High$2.34
52W Low$1.13
Volume—
Avg Volume1.48M
Market Cap344.30M
P/E Ratio—
EPS$-0.08
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,041.3% upside
Current
$1.42
$1.42
Target
$16.15
$16.15
$10.52
$16.15 avg
$19.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 892.38M | 811.70M | 59.12M |
| Net Income | -14,866,890 | -12,170,457 | 16.50M |
| Profit Margin | -1.7% | -1.6% | 27.9% |
| EBITDA | 41.44M | 35.81M | 25.74M |
| Free Cash Flow | — | — | 14.78M |
| Rev Growth | +9.9% | +9.9% | +13.8% |
| Debt/Equity | 0.15 | 0.15 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |